Showing results (61-70 of 2,434) with videos related to

Sort By:
Pageof 244
Clinical and Translational Science|July 21, 2017
Leveraging a Clinical Phase Ib Proof-of-Concept Study for the GPR40 Agonist MK-8666 in Patients With Type 2 Diabetes for Model-Informed Phase II Dose SelectionA W Krug, P Vaddady, R A Railkar, et al.
Clinical and Translational Science|December 15, 2015
The Changing Faces of Mentorship: Application of a Developmental Network Framework in a Health Services Research Career Development ProgramMax A Halvorson, John W Finney, Xiaoyu Bi, et al.
Clinical and Translational Science|July 24, 2022
Prolonged activated partial thromboplastin time predicts poor short-term prognosis in patients with acute pancreatitis: A retrospective cohort studyYuping Yang, Shenshen Du, Weinan Yuan, et al.
Clinical and Translational Science|September 25, 2019
Comparing Model Performance in Characterizing the PK/PD of the Anti-Myostatin Antibody DomagrozumabAbhinav Tiwari, Indranil Bhattacharya, Phylinda L S Chan, et al.
Clinical and Translational Science|March 19, 2019
Exposure-Response Analysis of Overall Survival for Tremelimumab in Unresectable Malignant Mesothelioma: The Confounding Effect of Disease StatusPaul Baverel, Lorin Roskos, Manasa Tatipalli, et al.
Clinical and Translational Science|September 10, 2019
Impact of Disease and Treatment Response in Drug-Drug Interaction Studies: Osimertinib and Simvastatin in Advanced Non-Small Cell Lung CancerKarthick Vishwanathan, Mireille Cantarini, Karen So, et al.
Clinical and Translational Science|September 20, 2019
Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic ActivityRachel Dalton, Seung-Been Lee, Katrina G Claw, et al.
Clinical and Translational Science|October 2, 2019
The Influences of Adherence to Tamoxifen and CYP2D6 Pharmacogenetics on Plasma Concentrations of the Active Metabolite (Z)-Endoxifen in Breast CancerJeanine Marie Nardin, Werner Schroth, Thais Abreu Almeida, et al.
Clinical and Translational Science|November 15, 2018
Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp Substrates in Patients With an Advanced Solid TumorJim J Xiao, Dorota Nowak, Rodryg Ramlau, et al.
Clinical and Translational Science|February 23, 2021
Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19Annie Delaunois, Matthew Abernathy, Warren D Anderson, et al.
Pageof 244